146 related articles for article (PubMed ID: 27612088)
1. Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity.
Miao X; Zhang W; Huang Z; Li N
PLoS One; 2016; 11(9):e0162405. PubMed ID: 27612088
[TBL] [Abstract][Full Text] [Related]
2. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
[TBL] [Abstract][Full Text] [Related]
3. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin CD151 and integrin α6β1 mediate platelet-enhanced endothelial colony forming cell angiogenesis.
Huang Z; Miao X; Patarroyo M; Nilsson GP; Pernow J; Li N
J Thromb Haemost; 2016 Mar; 14(3):606-18. PubMed ID: 26749288
[TBL] [Abstract][Full Text] [Related]
5. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
6. Annexin V binding to platelets is agonist, time and temperature dependent.
Ramstrom S; O'Neill S; Dunne E; Kenny D
Platelets; 2010; 21(4):289-96. PubMed ID: 20230207
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
8. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
9. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
12. Platelet PAR1 receptor density--correlation to platelet activation response and changes in exposure after platelet activation.
Ramström S; Oberg KV; Akerström F; Enström C; Lindahl TL
Thromb Res; 2008; 121(5):681-8. PubMed ID: 17675219
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
14. Quantification of platelet function - a comparative study of venous and arterial blood using a novel flow cytometry protocol.
Törnudd M; Rodwan Al Ghraoui M; Wahlgren S; Björkman E; Berg S; Kvitting JP; Alfredsson J; Ramström S
Platelets; 2022 Aug; 33(6):926-934. PubMed ID: 35073813
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Platelets Selectively Activated by Protease-Activated Receptors on Meniscal Cells.
Xu H; Zou X; Xia P; Aboudi MAK; Chen R; Huang H
Am J Sports Med; 2020 Jan; 48(1):197-209. PubMed ID: 31765237
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1.
Miao X; Rahman MF; Jiang L; Min Y; Tan S; Xie H; Lee L; Wang M; Malmström RE; Lui WO; Li N
J Thromb Haemost; 2018 Apr; 16(4):791-801. PubMed ID: 29442415
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
18. The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus.
Mahmoodian R; Salimian M; Hamidpour M; Khadem-Maboudi AA; Gharehbaghian A
BMC Endocr Disord; 2019 Jun; 19(1):62. PubMed ID: 31200678
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.
Yang S; Zhao J; Chen Y; Lei M
Cardiovasc Toxicol; 2016 Jul; 16(3):213-22. PubMed ID: 26175178
[TBL] [Abstract][Full Text] [Related]
20. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
